Skip to content

Inspired Helium for Ischemic Protection During Knee Replacement Surgery

Inspired Helium for Ischemic Protection During Knee Replacement Surgery

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02012361
Enrollment
40
Registered
2013-12-16
Start date
2014-10-31
Completion date
2016-08-31
Last updated
2019-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia

Keywords

Ischemic preconditioning, Human limb ischemia, Total knee arthroplasty, Supplemental inspired helium

Brief summary

The purpose of this study is to determine whether breathing in helium reduces indications of injury to the skeletal muscle seen in blood tests after knee replacement surgery. The ability to reduce the risk of skeletal muscle injury may help improve patient safety by providing protection to the area of the body having its blood supply interrupted during a particular surgery.

Detailed description

During hospitalization, beginning the day after surgery, additional tests will be added to the daily standard of care blood samples. When daily blood samples are not ordered as part of a study participants care after surgery, blood samples only for the study tests, may be done. Up to 60 study participants will be selected to be in one of two possible groups. After hospital discharge the study participants physical therapist will be contacted for copies of the notes and reports about the participants progress in physical therapy. This information will be used to evaluate if the different breathing gases have any impact on how quickly people recover after surgery.

Interventions

PROCEDUREControl Group

This group will be treated as any other patient would. Their anesthesia will be conducted as per routine with a target FiO2 of 0.25, (25%oxygen / 75%nitrogen) the only exception being that they will not be treated with inspired heliox.

PROCEDURESingle-Dose Heliox Group

This group will be treated with a single dose of inspired 75/25 heliox (75% helium 25% oxygen) breathed continuously for 15 minutes over any convenient window prior to the inflation of the surgical tourniquet. This will be the only change in their clinical care. Their anesthesia will be conducted as per routine and as the anesthesia team sees fit with a target FiO2 of 0.25, the only exception being that they will receive 75/25 heliox prior to the inflation of the tourniquet.

PROCEDUREMuscle Biopsy

During the course of the operation a small muscle biopsy will be collected.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Scheduled for an elective total knee arthroplasty * \> 18 years of age * Expected to require inhaled oxygen concentrations \< 25% * Able to provide informed consent

Exclusion criteria

* Expected to require inhaled oxygen concentrations \> 25% * \< 18 years of age * Member of a defined vulnerable population (e.g. pregnant, mentally handicapped, prisoners, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Expression of serum markersup to 5 daysPost-operative expression of serum markers of injury to the skeletal muscle after knee arthroplasty. The primary endpoint will be detection of a decrease in the peak increase of CK detectable in the blood. A 15% decrease will be considered clinically significant.

Secondary

MeasureTime frameDescription
Recovery of quadriceps functionUp to one yearLength of time of transition from a walker to a cane.

Other

MeasureTime frameDescription
Post-surgical time course of lactic acidup to 5 daysChanges in the time course of the peak level of expression of lactic acid will be analyzed.
Post-surgical time course of lactate dehydrogenaseup to 5 daysChanges in the time course of the peak level of expression of lactate dehydrogenase will be analyzed..
Post-surgical time course of potassiumup to 5 daysChanges in the time course of the peak level of expression of potassium will be analyzed.
Post-surgical time course of creatinine phosphokinase (CK)up to 5 daysChanges in the time course of the peak level of expression of creatinine phosphokinase (CK) will be analyzed.
Post-surgical time course of aldolaseup to 5 daysChanges in the time course of the peak level of expression of aldolase will be analyzed.
Post-surgical time course of urea (BUN)up to 5 daysChanges in the time course of the peak level of expression of urea (BUN) will be analyzed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026